EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SLS BIO Co's Enterprise Value is ₩29,802 Mil.
SLS BIO Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,280 Mil. Therefore, SLS BIO Co's EV-to-FCF for today is 23.28.
The historical rank and industry rank for SLS BIO Co's EV-to-FCF or its related term are showing as below:
XKRX:246250'
s EV-to-FCF Range Over the Past 10 Years
Min: 8.44 Med: 13.38 Max: 29.92
Current: 22.9
During the past 9 years, the highest EV-to-FCF of SLS BIO Co was 29.92. The lowest was 8.44. And the median was 13.38.
XKRX:246250's EV-to-FCF is ranked better than 53.19% of 94
companies
in the Medical Diagnostics & Research industry
Industry Median: 25.03
vs XKRX:246250: 22.90
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-26), SLS BIO Co's stock price is ₩4810.00.
SLS BIO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩77.415. Therefore, SLS BIO Co's PE Ratio for today is 62.13.
SLS BIO Co EV-to-FCF Historical Data
The historical data trend for SLS BIO Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, SLS BIO Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SLS BIO Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SLS BIO Co's EV-to-FCF falls into.
SLS BIO Co EV-to-FCF Calculation
SLS BIO Co's EV-to-FCF for today is calculated as:
SLS BIO Co's current Enterprise Value is ₩29,802 Mil.
SLS BIO Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,280 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SLS BIO Co (XKRX:246250) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SLS BIO Co's share price for today is ₩4810.00.
SLS BIO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩77.415.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SLS BIO Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of SLS BIO Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:246250 has been successfully added to your 